← Back
Oncology

Sacituzumab tirumotecan (sac-TMT)

MSD / Kelun-Biotech

Next-generation TROP2 ADC. OptiTROP-Breast trials head-to-head vs sacituzumab govitecan.

HR+ Breast CancerTNBC

Linked Studies

NCT05184218PrimaryTERMINATEDPHASE1

Evaluation of IGM-6268 in Healthy Adults and Patients With Mild to Moderate COVID-19

Healthy VolunteersCOVID-19Updated Oct 2022
Loading comments…

Also Known As

Other names

sacituzumab
Search all trials →Request coverage update